Medicare Enrolled

Dr. Kathy Rosema, DO

Family Medicine · Shelby, MI
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Low-engagement
119 S STATE ST, Shelby, MI 49455
2318612130
In practice since 2006 (20 years)
NPI: 1689628927 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosema from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosema? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosema

Dr. Kathy Rosema is a family medicine specialist in Shelby, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rosema performed 228 Medicare services across 114 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rosema received a total of $5,690 from 47 pharmaceutical and/or device companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosema is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 228 Medicare services $5,690 industry payments

Medicare Practice Summary

Medicare Utilization ↗
228
Medicare services
Bottom 40% in MI for family medicine
114
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
129 $3 $11
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
82 $10 $26
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
17 $2 $15
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,690
Total received (2018-2024)
Avg $813/year across 7 years
Top 7% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
349
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,690 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,389
2023
$745
2022
$428
2021
$632
2020
$395
2019
$1,137
2018
$965

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$367
ABBVIE INC.
$242
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$210
Teva Pharmaceuticals USA, Inc.
$99
Novo Nordisk Inc
$75
Lundbeck LLC
$62
Lilly USA, LLC
$44
GlaxoSmithKline, LLC.
$39
Bayer Healthcare Pharmaceuticals Inc.
$33
Axsome Therapeutics, Inc.
$28
Exact Sciences Corporation
$26
Neurocrine Biosciences, Inc.
$24
Astellas Pharma US Inc
$24
Otsuka America Pharmaceutical, Inc.
$23
Xeris Pharmaceuticals, Inc.
$22
Gilead Sciences, Inc.
$19
Tempus AI, Inc
$18
Braeburn Inc.
$17
Amgen Inc.
$16
Top 3 companies account for 59.0% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$838
Sunovion Pharmaceuticals Inc.
$557
PFIZER INC.
$425
Novo Nordisk Inc
$418
ABBVIE INC.
$305
AbbVie Inc.
$251
Otsuka America Pharmaceutical, Inc.
$247
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$210
ITI, Inc.
$194
Vanda Pharmaceuticals Inc.
$163
AstraZeneca Pharmaceuticals LP
$156
Teva Pharmaceuticals USA, Inc.
$147
Lundbeck LLC
$147
GlaxoSmithKline, LLC.
$142
Amgen Inc.
$140
Allergan Inc.
$102
Lilly USA, LLC
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Takeda Pharmaceuticals U.S.A., Inc.
$91
Bayer Healthcare Pharmaceuticals Inc.
$74
Grifols USA, LLC
$70
Xeris Pharmaceuticals, Inc.
$65
Novartis Pharmaceuticals Corporation
$64
E.R. Squibb & Sons, L.L.C.
$55
Alkermes, Inc.
$54
Exact Sciences Corporation
$47
Bayer HealthCare Pharmaceuticals Inc.
$44
Shire North American Group Inc
$42
Neurocrine Biosciences, Inc.
$42
Janssen Pharmaceuticals, Inc
$42
Astellas Pharma US Inc
$40
Hologic, LLC
$32
Philips Electronics North America Corporation
$30
Baxter Healthcare
$29
Axsome Therapeutics, Inc.
$28
RedHill Biopharma Inc.
$22
Ironshore Pharmaceuticals Inc.
$22
Surmodics, Inc.
$20
Hologic Sales and Service, LLC
$19
Gilead Sciences, Inc.
$19
Tempus AI, Inc
$18
AbbVie, Inc.
$18
Smith+Nephew, Inc.
$17
Braeburn Inc.
$17
Ironwood Pharmaceuticals, Inc
$14
Collegium Pharmaceutical, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ABILIFY MAINTENA · AJOVY · APTIMA · AREXVY · AUSTEDO · Aemcolo · Aimovig · Austedo XR · Auvelity · BEXSERO · BRIXADI · BYDUREON · CAMZYOS · CAPLYTA · CHANTIX · COLOGUARD · Cologuard Collection Kit · Creon · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FANAPT · FARXIGA · Fanapt · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Welch Allyn PanOptic Ophthalmoscope · INGREZZA · JANUVIA · JARDIANCE · Jornay PM 20mg capsules (Bottle of 100) · Kerendia · LATUDA · LINZESS · LONHALA MAGNAIR · LYRICA · MAVYRET · MYRBETRIQ · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · Prolastin-C Liquid · QULIPTA · Qelbree · REXULTI · Repatha · Rybelsus · STIOLTO RESPIMAT · SYMBICORT · Santyl · Saxenda · Sublime 014 Rx PTA Balloon Dilatation Catheter · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tresiba · Trintellix · UBRELVY · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Veozah · Wegovy · XARELTO · XTAMPZA · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in MI.

Looking for a family medicine specialist in Shelby?
Compare family medicine physicians in the Shelby area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
69
Per 100K population
257.6
County median income
$63,624
Nearest hospital
MERCY HEALTH LAKESHORE CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rosema is a remote monitoring specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rosema experienced with blood glucose test using hand-held instrument?
Based on Medicare claims data, Dr. Rosema performed 129 blood glucose test using hand-held instrument services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosema receive payments from pharmaceutical companies?
Yes. Dr. Rosema received a total of $5,690 from 47 companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosema's costs compare to other family medicine physicians in Shelby?
Dr. Rosema's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosema) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →